Journal article

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

GS Cooke, I Andrieux-Meyer, TL Applegate, R Atun, JR Burry, H Cheinquer, G Dusheiko, JJ Feld, C Gore, MG Griswold, S Hamid, ME Hellard, JL Hou, J Howell, J Jia, N Kravchenko, JV Lazarus, M Lemoine, OA Lesi, L Maistat Show all

Lancet Gastroenterology and Hepatology | ELSEVIER INC | Published : 2019

Abstract

Viral hepatitis is a major public health threat and a leading cause of death worldwide. Annual mortality from viral hepatitis is similar to that of other major infectious diseases such as HIV and tuberculosis. Highly effective prevention measures and treatments have made the global elimination of viral hepatitis a realistic goal, endorsed by all WHO member states. Ambitious targets call for a global reduction in hepatitis-related mortality of 65% and a 90% reduction in new infections by 2030. This Commission draws together a wide range of expertise to appraise the current global situation and to identify priorities globally, regionally, and nationally needed to accelerate progress. We identi..

View full abstract